GARDASIL9: payments to doctors
Payments that named GARDASIL9 as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $647K
- Providers
- 23,179
- Transactions
- 35,966
- Average per transaction
- $18
The per-transaction average — $18 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 23,179 providers the average total is $28, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Merck | $647,371 | 100.0% |